Major histocompatibility complex-dependent susceptibility to Cryptococcus neoformans in mice
- PMID: 12874366
- PMCID: PMC166009
- DOI: 10.1128/IAI.71.8.4815-4817.2003
Major histocompatibility complex-dependent susceptibility to Cryptococcus neoformans in mice
Abstract
To evaluate the role of major histocompatibility complex (MHC) genes in the resistance to Cryptococcus neoformans, we conducted infection experiments in MHC-congenic strains of mice. Significant MHC-dependent susceptibility differences were found among homozygotes and heterozygotes. This study is the first experimental demonstration of MHC-dependent susceptibility to C. neoformans infections in mice and indicates that MHC genes can be important in host resistance.
Figures
References
-
- Abrahams, I. 1966. Further studies on acquired resistance to murine cryptococcosis: enhancing effect of Bordetella pertussis. J. Immunol. 96:525-529. - PubMed
-
- Aguirre, K. M., and G. W. Gibson. 2000. Differing requirement for inducible nitric oxide synthase activity in clearance of primary and secondary Cryptococcus neoformans infection. Med. Mycol. 38:343-353. - PubMed
-
- Ashman, R. B. 1987. Mouse candidiasis. II. Host responses are T-cell dependent and regulated by genes in the major histocompatibility complex. Immunogenetics 25:200-203. - PubMed
-
- Baum, H., and N. A. Staines. 1997. MHC-derived peptides and the CD4+ T-cell repertoire: implications for autoimmune disease. Cytokines Cell. Mol. Ther. 3:115-125. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
